Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED
MovanoMovano(US:MOVE) Prnewswire·2024-11-04 13:00

Core Insights - Movano Health has submitted a complete response package to the FDA for the EvieMED Ring as part of the final phase of its 510(k) application review, expressing optimism about its potential for clearance [1][2] - The EvieMED Ring is a wearable device that combines medical device functionality with wellness metrics, including pulse oximetry, sleep, activity, mood, and energy logging [2][3] - Movano Health aims to develop healthcare solutions that provide medical-grade data through innovative wearable technologies, focusing on personalized health insights [3][4] Company Overview - Movano Health, founded in 2018, is focused on creating purpose-driven healthcare solutions that leverage wearable technology to deliver trusted health data [3] - The company is developing proprietary technologies and wearable medical devices to enhance proactive health monitoring and management across various patient populations [4]